XOM
42
5
KMI
69
4
DGX
33
-6
FRT
36
2
LEG
28
6
KMX
47
4
BF.B
31
2
GWW
64
-3
BEN
33
-5
EXR
48
2
TSCO
45
2
GOOG
55
-4
TEL
60
-6
CA
13
3
ES
48
-2
LOW
50
4
CSX
55
-2
L
47
-5
MMM
28
-2
HPE
38
-15
XOM
42
5
KMI
69
4
DGX
33
-6
FRT
36
2
LEG
28
6
KMX
47
4
BF.B
31
2
GWW
64
-3
BEN
33
-5
EXR
48
2
TSCO
45
2
GOOG
55
-4
TEL
60
-6
CA
13
3
ES
48
-2
LOW
50
4
CSX
55
-2
L
47
-5
MMM
28
-2
HPE
38
-15
Financhill
Back

Cassava Sciences 10K Form

Sell
32

SAVA
Cassava Sciences

Last Price:
25.17
Seasonality Move:
36.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-12 10Q SAVA/Cassava Sciences Quarterly
2020-05-06 10Q SAVA/Cassava Sciences Quarterly
2020-03-26 10K SAVA/Cassava Sciences Annual
2019-10-29 10Q SAVA/Cassava Sciences Quarterly
2019-08-12 10Q SAVA/Cassava Sciences Quarterly
2019-05-02 10Q SAVA/Cassava Sciences Quarterly

Receive SAVA News And Ratings

See the #1 stock for the next 7 days that we like better than SAVA

SAVA Financial Statistics

Sales & Book Value

Annual Sales: $41.12M
Cash Flow: $-18.27M
Price / Cash Flow: 0
Annual Sales: $3.94
Price / Book: 6.56

Profitability

EPS (TTM): -1.41000
Net Income (TTM): $-15.37M
Gross Margin: $20.56M
Return on Equity: 0%
Return on Assets: 0%

Cassava Sciences Earnings Forecast

Key Cassava Sciences Financial Ratios

  • The Gross Profit Margin over the past 11 years for SAVA is 100.00%.
  • The Selling, General & Administrative Expenses for SAVA have been equal to 11.77% of Gross Profit Margin.
  • Per Share Earnings over the last 25 years have been positive in 10 years.

Cassava Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SAVA
CUSIP: 14817C
Website: cassavasciences.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SAVA Technical Analysis vs Fundamental Analysis

Sell
32
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy or a Sell?

  • Cassava Sciences stock is rated a Sell
    The current Cassava Sciences [SAVA] share price is $25.84. The Score for SAVA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.